BANNOCKBURN, Ill. , March 01, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell 13,000,000 shares of the Company’s common stock
BANNOCKBURN, Ill. , April 18, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31,
BANNOCKBURN, Ill. , April 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health , Inc. (“Option Care Health”) (Nasdaq: OPCH) announces the formation of a nationwide home infusion nursing network and clinical platform that will operate as Naven Health, Inc. (“Naven Health”), focused on delivering
All-Stock Transaction Combines Highly Complementary Businesses Unlocking Significant Benefits for Patients, Providers, Payers, and Care Teams Increases Access to High Quality Care for Communities Across the U.S. through a Unique National Clinical Platform Comprehensive Capabilities Across Alternate
BANNOCKBURN, Ill. , May 3, 2023 /PRNewswire/ -- Option Care Health, Inc. (the "Company" or " Option Care Health ") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2023 .
BANNOCKBURN, Ill. , May 05, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will present at the BofA Securities Health Care Conference on Tuesday, May 9, 2023 in
BANNOCKBURN, Ill. , May 18, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: William Blair’s 43rd
Company to Deliver to Patients FDA-Approved Topical Treatment for Dystrophic Epidermolysis Bullosa (DEB) Announces Collaboration with Amedisys to Administer Treatment in the Home BANNOCKBURN, Ill. , May 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc.
Issues Statement in Light of Amedisys' Disclosure of Unsolicited Proposal from Optum BANNOCKBURN, Ill. , June 5, 2023 /PRNewswire/ -- Option Care Health, Inc. (" Option Care Health ") (Nasdaq: OPCH) today filed with the U.S. Securities and Exchange Commission a registration statement on Form S-4
Highlights Strength of Platform and Track Record of Execution and Value Creation BANNOCKBURN, Ill. , June 26, 2023 /PRNewswire/ -- Option Care Health, Inc. (" Option Care Health " or the "Company") (Nasdaq: OPCH) today announced that it has terminated its previously announced agreement to combine
